Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002895 (
sickle cell disease
)
11,747
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Chronic lung disease
is a significant source of morbidity and mortality in patients with
sickle cell disease
. Asthma and sickle cell lung disease share many of the same clinical features and pathophysiological mechanisms. Though there is growing evidence of an association between
sickle cell disease
and airway hyper-reactivity, there is still no consensus on the definition of asthma in sickle cell lung disease. This review will explore what we know about asthma and airway hyper-reactivity in
sickle cell disease
and whether currently available asthma therapies may be beneficial in delaying or averting the progression of sickle cell lung disease.
...
PMID:Asthma and chronic sickle cell lung disease: a dynamic relationship. 2117 79
The pulmonary complications of
sickle cell disease
are a major cause of morbidity and mortality in affected patients. The acute chest syndrome (ACS) is a leading cause of death in patients with
sickle cell disease
and has a multifactorial etiology. Hydroxyurea (HU), stem cell transplantation (SCT) and chronic transfusions are known to prevent the recurrence of ACS. Careful management of patients admitted for pain crises and surgery including use of incentive spirometry is critical in preventing this complication. Pulmonary hypertension is well known to be associated with
sickle cell disease
and patients with pulmonary hypertension have increased mortality. Asthma is also commonly seen in patients with
sickle cell disease
and is associated with a more complicated course.
Chronic lung disease
develops in a significant proportion of patients with
sickle cell disease
.
...
PMID:Pulmonary complications of sickle cell disease. 2197 51